Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 43 Stomach Neoplasms 42 Rectal Neoplasms 28 Pancreatic Neoplasms 17 Lymphoma, Large B-Cell, Diffuse 13 Colonic Neoplasms 13 Cholangiocarcinoma 11 Neoplasm Metastasis 10 Adenocarcinoma 10 Neoplasms 9 Carcinoma, Hepatocellular 8 Carcinoma, Non-Small-Cell Lung 7 Biliary Tract Neoplasms 7 Locally Advanced Rectal Cancer 6 Gastrointestinal Neoplasms 6 Gallbladder Neoplasms 6 Esophageal Neoplasms 6 Adenocarcinoma Of Esophagus 6 Peritoneal Neoplasms 5 Recurrence 4 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 3 Carcinoma 3 Bile Duct Neoplasms 3 Appendiceal Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Pathologic Complete Response 2 Melanoma 2 Lymphoma, Non-Hodgkin 2

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ampullary Adenocarcinoma × Oxaliplatin × Clear all

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡